The research of hepatoprotective activity in experimental hepatitis influenced by 1,2,4-triazole derivatives

Authors

  • I. M. Bilay
  • E. O. Mihayluk
  • V. V. Parchenko
  • A. G. Kaplaushenko
  • A. I. Panasenko
  • E. G. Knysh

DOI:

https://doi.org/10.14739/2409-2932.2014.2.26165

Keywords:

Pharmacological Actions, Drug Screening, Animal Experimental, Toxic Hepatitis, 1, 2, 4-triazole

Abstract

Aim. The search of new high-effective drugs is an actual problem of modern science. The purpose of our research was the pharmacological screening of 1,2,4-triazoles derivatives. Experiments have been performed on adult Wistar white rats.

Methods and results. Compounds have been entered in a 1/10 dose of LD50, which have been determined before performing experiments. The article presents hepatoprotective activity of new synthesized compounds in simulated acute liver injury. We present a comparison with reference drugs in the experiment.

Сonclusion. Screening has shown that these class of compounds is promising for further research.

References

Stefanov, O. V. (Ed.) (2001) Doklinichni doslidzhenia likarskikh zakhodiv [Preclinic investigation medicines]. Kyiv: Avicena. [in Ukrainian].

Morozov, S. Yu. (2009) Gepatoprotektory v praktike vracha-klinicista [Hepatoprotectors in practic work of clinic doctor]. Russkij medicinskij zhurnal, 11(1), 25. [in Russian].

Polunina, T. E., Maev, I. V., & Polunina, E. V. (2009) Hepatologiya dlya practicheskogo vracha [Hepatology for practic doctor]. Moscow: Avtorskaya academiya. [in Russian].

Prozorovskii, V. B. (2007) Statisticheskaya obrabotka rezul'tatov farmakologicheskikh issledovanij [Statistic processing of data of pharmacological investigations]. Psikhofarmakologiya i biologicheskaya narkologiya, 7(3-4), 2090–2120. [in Russian].

Tkach, S. M. (2009) [Effectiveness and safety hepatoprotectors terms of evidence-based medicine]. Zdorov`e Ukrainy, 6, 7–10. [inUkrainian].

Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., et al. (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non–alcoholic fatty liver disease. J Clin Invest, 115(5), 1343–1351.

How to Cite

1.
Bilay IM, Mihayluk EO, Parchenko VV, Kaplaushenko AG, Panasenko AI, Knysh EG. The research of hepatoprotective activity in experimental hepatitis influenced by 1,2,4-triazole derivatives. Current issues in pharmacy and medicine: science and practice [Internet]. 2014Jul.8 [cited 2024Oct.10];(2). Available from: http://pharmed.zsmu.edu.ua/article/view/26165

Issue

Section

Experimental and clinical pharmacology